Metraipolis › archive › dc_c15af6904513
Topical exposure to triclosan inhibits Th1 immune responses and reduces T cells responding to influenza infection in mice — Europe PMC PMID:33373420
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/33373420
- DOI
- 10.1371/journal.pone.0244436
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-06T12:40:39.443Z
- SHA-256 of the archived text
1943b7b6c25ad3d22f5484b8c520101b565cf8d2bd089d1b5d2258d4eb32337f- Stable URL of this page
https://metraipolis.com/documento/dc_c15af6904513
How to cite
Topical exposure to triclosan inhibits Th1 immune responses and reduces T cells responding to influenza infection in mice — Europe PMC PMID:33373420 — Europe PMC (en), https://europepmc.org/article/MED/33373420 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_c15af6904513 (Metraipolis archive dc_c15af6904513, sha256 1943b7b6c25ad3d22f5484b8c520101b565cf8d2bd089d1b5d2258d4eb32337f)
BibTeX
@misc{dcc15af6904513,
title = {Topical exposure to triclosan inhibits Th1 immune responses and reduces T cells responding to influenza infection in mice — Europe PMC PMID:33373420},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/33373420},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_c15af6904513; sha256 1943b7b6c25ad3d22f5484b8c520101b565cf8d2bd089d1b5d2258d4eb32337f},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/33373420. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Healthcare workers concurrently may be at a higher risk of developing respiratory infections and allergic disease, such as asthma, than the general public. Increased incidence of allergic diseases is thought to be caused, in part, due to occupational exposure to chemicals that induce or augment Th2 immune responses. However, whether exposure to these chemical antimicrobials can influence immune responses to respiratory pathogens is unknown. Here, we use a BALB/c murine model to test if the Th2-promoting antimicrobial chemical triclosan influences immune responses to influenza A virus. Mice were dermally exposed to 2% triclosan for 7 days prior to infection with a sub-lethal dose of mouse adapted PR8 A(H1N1) virus (50 pfu); triclosan exposure continued until 10 days post infection (dpi). Infected mice exposed to triclosan did not show an increase in morbidity or mortality, and viral titers were unchanged. Assessment of T cell responses at 10 dpi showed a decrease in the number of total and activated (CD44hi) CD4+ and CD8+ T cells at the site of infection (BAL and lung) in triclosan exposed mice compared to controls. Influenza-specific CD4+ and CD8+ T cells were assessed using MHCI and MHCII tetramers, with reduced populations, although not reaching statistical significance at these sites following triclosan exposure. Reductions in the Th1 transcription factor T-bet were seen in both activated and tetramer+ CD4+ and CD8+ T cells in the lungs of triclosan exposed infected mice, indicating reduced Th1 polarization and providing a potential mechanism for numerical reduction in T cells. Overall, these results indicate that the immune environment induced by triclosan exposure has the potential to influence the developing immune response to a respiratory viral infection and may have implications for healthcare workers who may be at an increased risk for developing infectious diseases. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2020 (prima pubblicazione 2020-12-29). Identificativi: PMID 33373420 · PMCID PMC7771851 · DOI 10.1371/journal.pone.0244436. Descrittori MeSH principali: Health Personnel. Pagina: https://europepmc.org/article/MED/33373420 — https://doi.org/10.1371/journal.pone.0244436. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-06T12:37:54.645Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.